News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303 Results
Type
Article (15)
Press Release (288)
Section
Business (66)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
Best Places to Work (40)
Cancer (3)
Clinical research (67)
COVID-19 (5)
Data (5)
Diagnostics (5)
Earnings (33)
Events (73)
FDA (14)
Government (6)
Healthcare (6)
Infectious disease (5)
IPO (11)
Job creations (1)
Liver cancer (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2025 (6)
Pancreatic cancer (1)
Patents (2)
Patient recruitment (1)
People (16)
Phase I (49)
Phase II (39)
Phase III (15)
Pipeline (4)
Preclinical (18)
Real estate (1)
Regulatory (15)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 30 days (4)
Last 365 days (22)
2025 (22)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (1)
Europe (3)
Texas (23)
United States (23)
303 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Issues New Positive AML Overall Survival Data:
August 28, 2025
·
9 min read
Press Releases
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
August 29, 2025
·
5 min read
Press Releases
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
September 10, 2025
·
8 min read
Press Releases
Moleculin Reports Second Quarter 2025 Financial Results and Highlights
August 14, 2025
·
12 min read
Press Releases
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025
·
3 min read
Press Releases
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
September 9, 2025
·
7 min read
Press Releases
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
July 31, 2025
·
5 min read
Press Releases
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
August 7, 2025
·
7 min read
Press Releases
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
July 10, 2025
·
8 min read
Press Releases
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
June 19, 2025
·
7 min read
1 of 31
Next
